COOPER COMPANIES, INC.
COO · Ophthalmic Goods
Latest available SEC filing: 4 ·
Latest disclosures
-
Kurzius Lawrence Erik: Form 4
Insider disclosure · Filed · Report period 16 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000711404 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- COO on Nasdaq
- SEC industry group
- Ophthalmic Goods (Industrial Applications and Services)
- Business address
- 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, 94583
- Incorporated in
- DE
- Fiscal year end
- 31 October
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields